About CIT
Company Overview
CIT, operating under the domain capitalinvestmentstrust.com, is an entity registered in New Zealand. According to our records, it was founded on 22 December 2021, with a registered address at 38k Lunn Avenue, Mount Wellington, Auckland, 1072. The company presents itself through a tiered account structure that suggests a focus on investment or trading services.
Our review found that minimal public information is available about CIT’s operations beyond its registration details. The lack of independently verifiable web presence or user reviews makes it difficult to assess its actual business activities. The entity appears to cater to clients with substantial capital, as indicated by its account minimums.
Regulatory Status
CIT does not hold a regulatory licence from any recognised financial authority. Our records show no regulators on file for this broker. This absence of oversight is a significant point for potential clients to consider, as regulated brokers are subject to strict operational standards and client fund protection requirements.
In New Zealand, financial service providers are typically required to register with the Financial Markets Authority (FMA) or obtain a licence if offering certain services. However, being registered as a company does not equate to regulatory authorisation for investment services. Traders should exercise caution when dealing with unregulated entities.
Account Types and Minimum Deposits
CIT offers four distinct account tiers, each with progressively higher minimum deposit thresholds. The Starter account requires a deposit between $100 and $999, while the Professional account requires $1,000 to $4,999. The Enterprise account is designed for deposits ranging from $5,000 to $15,000, and the Mega Plan requires a minimum deposit of $15,000 with no upper limit.
The Mega Plan is described as offering 'Cumulative Compounding', which may indicate a focus on reinvesting returns. Notably, no maximum leverage is specified for any account type. This structure, particularly the unlimited deposit ceiling on the highest tier, suggests that CIT targets high-net-worth individuals or institutional clients.
Tradable Instruments
Our records do not list any specific tradable instruments offered by CIT. The absence of this information makes it impossible to determine whether the broker provides forex, CFDs, commodities, indices, or other asset classes. Without clarity on what clients can trade, assessing the suitability of the platform is challenging.
Potential clients should seek detailed information about available instruments directly from the broker, as this is a fundamental aspect of any trading or investment service. The lack of disclosure in public sources is a red flag that warrants further investigation.
Target Audience
Based on the account tier minimums, CIT appears to target investors with significant capital, particularly those interested in high-value investment programmes. The absence of a standard retail account under $100 indicates that it is not aimed at novice or small-scale traders. Rather, its offering seems designed for experienced or accredited investors.
The focus on high minimum deposits and cumulative compounding in the Mega Plan suggests a strategy that may appeal to those seeking long-term growth through reinvestment. However, without regulatory oversight or transparent operational details, the risks involved are considerably elevated.
Conclusion
CIT is a New Zealand-registered entity with no regulatory oversight and limited public information. Its account structure is geared towards high-deposit clients, but the lack of disclosed instruments and operational transparency raises significant concerns. Our FXCanary Scam Risk Score of 52/100 (Elevated) reflects these uncertainties.
Traders considering CIT should conduct thorough due diligence, including verifying the company’s claims directly and seeking independent legal or financial advice. The absence of independent reviews and regulatory protection underscores the need for caution.
Overview compiled by FXCanary from regulatory records and public data. full CIT review